Slate Bio, Inc. — Form D/A
Slate Bio, Inc. of CHARLOTTESVILLE, VA, a company, filed a Form D amendment with the SEC on 2023-05-25. The offering totals $3.0M, of which $2.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-05-25
- Form: D/A
- Accession: 0001862143-23-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.8M
- Remaining: $223K
- Investors: 9
- Date of first sale: 2022-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-470922
Issuer
- Name: Slate Bio, Inc.
- CIK: 0001862143
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 310 2ND STREET SE, SUITE B, CHARLOTTESVILLE, VA, 22902
- Phone: 703-456-8000
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Robert Creeden | Director | Washington, DC |
| Brian Gallagher | Director | New York, NY |
| Andrew Krouse | Director | Charlottesville, VA |
| Kyparissia Sirinakis | Director | Charlottesville, VA |
| Andrew Krouse | Executive Officer | Charlottesville, VA |
| Kurt Woerpel | Executive Officer | Charlottesville, VA |
| Robert J Creeden | Director | Charlottesville, VA |
| Kurt J Woerpel | Executive Officer | Charlottesville, VA |
| Kyparissia J Sirinakis | Director | Charlottesville, VA |
| Andrew J Krouse | Director | Charlottesville, VA |
| Andrew J Krouse | Executive Officer | Charlottesville, VA |
Other filings by this issuer (2)
More